NCT01576666 Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01558947 Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01542294 SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01528059 Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes Status UNKNOWN Phase PHASE2/PHASE3
NCT01522768 Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer Status COMPLETED Phase PHASE2
NCT01518023 Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy Status COMPLETED Phase N/A
NCT01517009 A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer Status COMPLETED Phase PHASE2
NCT01516944 Perioperative Chemotherapy for Potentially Resectable Gastric Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01515748 Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01498289 S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT01497964 Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT01491698 Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma Status COMPLETED Phase PHASE3
NCT01471756 Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia Status COMPLETED Phase PHASE4
NCT01471132 Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis Status UNKNOWN Phase PHASE2
NCT01470742 Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer Status WITHDRAWN Phase PHASE3